“…Based on initial protocols developed with mouse and human ESCs (Eiraku et al, 2011;Nakano et al, 2012), different groups including ours developed three-dimensional (3D) culture systems recapitulating key steps of retinal development and allowing the generation of self-organizing retinal organoids containing RGCs (Reichman et al, 2014;Zhong et al, 2014;Maekawa et al, 2015;Ohlemacher et al, 2016;Fligor et al, 2018). Very recently, RGCs were differentiated from human induced pluripotent stem cells (hiPSCs) using a chemically defined medium resulting in dual SMAD and Wnt inhibition bypassing retinal organoid formation (Chavali et al, 2020). Patient-specific iPSCs can be useful to better characterize the pathogenesis and molecular mechanisms of different inherited optic neuropathies (Chen et al, 2016;Ohlemacher et al, 2016;Wu et al, 2018;VanderWall et al, 2020).…”